UTHSC Center for Sickle Cell Disease Trials

UTHSC Center for Sickle Cell Disease	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ataga, Kenneth

NCT03277547: Kidney Function in Sickle Cell Anemia

Active, not recruiting

N/A

300

Kenneth Ataga MD, Ohio State University, University of North Carolina

Sickle Cell Disease, Kidney Failure, Chronic

06/25

12/25

NCT04380610: Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

Recruiting

N/A

400

iohexol GFR

University of Alabama at Birmingham, National Heart, Lung, and Blood Institute (NHLBI)

Sickle Cell Disease, Renal Disease, Glomerular Disease

05/25

PREMIER, NCT05214105: The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia

Recruiting

N/A

400

Biospecimen/DNA collection and analysis

University of Tennessee, National Heart, Lung, and Blood Institute (NHLBI), University of Illinois at Chicago, University of Memphis, University of North Carolina, Charlotte, Wake Forest University, University of North Carolina, Chapel Hill

Sickle Cell Disease, Kidney Diseases, Chronic

01/26

SCCRIP, NCT02098863: Sickle Cell Clinical Research and Intervention Program

Recruiting

N/A

10000

St. Jude Children's Research Hospital, University of Memphis School of Public Health, Le Bonheur Children's Hospital, University of Alabama at Birmingham, Washington University School of Medicine, UTHSC-ORNL Center in Biomedical Informatics, University of Washington, Medical College of Wisconsin, University of Tennessee, Children's Hospital of Philadelphia, National Heart, Lung, and Blood Institute (NHLBI), Vanderbilt University School of Medicine, Baylor College of Medicine

Sickle Cell Disease

12/44



	Diseases Companies Products Productz Mechanisms of Action Sites